EPISODE · Oct 19, 2022 · 44 MIN
Netflix’s Earnings Rebound, Surveying the Airline Stocks, and BioMarin CEO 10/19/22
from Mad Money w/ Jim Cramer · host CNBC
Netflix soared today after earnings, and Jim Cramer’s walking you through how the streaming company pulled it off this quarter. Then, are Delta and United worth buying after rebounding from their lows? Cramer’s giving you his take on owning the airlines. And, Cramer’s sitting down with the Chairman and CEO of BioMarin Pharmaceutical, to get a closer look at the company’s pipeline and where the stock could be headed. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
Netflix soared today after earnings, and Jim Cramer’s walking you through how the streaming company pulled it off this quarter. Then, are Delta and United worth buying after rebounding from their lows? Cramer’s giving you his take on owning the airlines. And, Cramer’s sitting down with the Chairman and CEO of BioMarin Pharmaceutical, to get a closer look at the company’s pipeline and where the stock could be headed.
NOW PLAYING
Netflix’s Earnings Rebound, Surveying the Airline Stocks, and BioMarin CEO 10/19/22
No transcript for this episode yet
Similar Episodes
Apr 29, 2025 ·12m
Apr 27, 2025 ·11m
Apr 24, 2025 ·11m
Apr 22, 2025 ·14m